Details for New Drug Application (NDA): 203952
✉ Email this page to a colleague
NDA 203952 describes DUOPA, which is a drug marketed by Abbvie and is included in one NDA. It is available from one supplier. Additional details are available on the DUOPA profile page.
The generic ingredient in DUOPA is carbidopa; levodopa. There are eighteen drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the carbidopa; levodopa profile page.
The generic ingredient in DUOPA is carbidopa; levodopa. There are eighteen drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the carbidopa; levodopa profile page.
Summary for 203952
| Tradename: | DUOPA |
| Applicant: | Abbvie |
| Ingredient: | carbidopa; levodopa |
| Patents: | 0 |
Suppliers and Packaging for NDA: 203952
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| DUOPA | carbidopa; levodopa | SUSPENSION;ENTERAL | 203952 | NDA | AbbVie Inc. | 0074-3012 | 0074-3012-07 | 7 CARTRIDGE in 1 CARTON (0074-3012-07) / 100 mL in 1 CARTRIDGE |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SUSPENSION;ENTERAL | Strength | 4.63MG/ML;20MG/ML | ||||
| Approval Date: | Jan 9, 2015 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
